Angiotensin II type 1 receptor blocker inhibits arterial calcification in a pre-clinical model

Cardiovascular Research

Volumn 90, Issue 1, 2011, Pages 165-170

  Armstrong, Zachary B ^a   Boughner, Derek R ^a,b   Drangova, Maria ^a,b   Rogers, Kem A ^a  

^a WESTERN UNIVERSITY   (Canada)

^b ROBARTS RESEARCH INSTITUTE   (Canada)

Author keywords

Angiotensin receptor blocker; Arterial calcification; Pre clinical model; Vascular smooth muscle cells

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; BIOLOGICAL MARKER; BONE MORPHOGENETIC PROTEIN 2; CHOLESTEROL; OLMESARTAN; OSTEOCALCIN; PHOSPHATE; PROTEIN RAM11; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY CALCIFICATION; ARTERY MEDIA; ARTICLE; ATHEROGENIC DIET; ATHEROSCLEROTIC PLAQUE; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL INTAKE; CONTROLLED STUDY; DOWN REGULATION; EXPERIMENTAL RABBIT; IMMUNOHISTOCHEMISTRY; MACROPHAGE; MALE; MICRO-COMPUTED TOMOGRAPHY; NONHUMAN; OSTEOBLAST; PHENOTYPIC VARIATION; PHOSPHATE BLOOD LEVEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SMOOTH MUSCLE FIBER; UPREGULATION;

ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; ATHEROSCLEROSIS; BONE MORPHOGENETIC PROTEIN 2; CALCINOSIS; DIET, ATHEROGENIC; DISEASE MODELS, ANIMAL; IMIDAZOLES; MALE; MUSCLE, SMOOTH, VASCULAR; MYOCYTES, SMOOTH MUSCLE; OSTEOBLASTS; OSTEOCALCIN; PHENOTYPE; RABBITS; RECEPTOR, ANGIOTENSIN, TYPE 1; TETRAZOLES; TIME FACTORS; X-RAY MICROTOMOGRAPHY;

EID: 79952849800     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvq391     Document Type: Article

References (42)

1. Blacher J, Guerin AP, Pannier B, Marchais SJ, London GM. Arterial calcifications, arterial stiffness, and cardiovascular risk in end-stage renal disease. Hypertension 2001;38: 938-942. (Pubitemid 34258697)
2. Jeffcoate WJ, Rasmussen LM, Hofbauer LC, Game FL. Medial arterial calcification in diabetes and its relationship to neuropathy. Diabetologia 2009;52:2478-2488.
3. Takasu J, Budoff MJ, Katz R, Rivera JJ, O'Brien KD, Shavelle DM et al. Relationship between common carotid intima-media thickness and thoracic aortic calcification: the Multi-Ethnic Study of Atherosclerosis. Atherosclerosis 2010;209:142-146.
4. Virchow R. Cellular Pathology. As based upon physiological and pathological histology. Lecture XVI-atheromatous affection of arteries. 1858. Nutr Rev 1989;47: 23-25.
5. Shroff RC, Shanahan CM. The vascular biology of calcification. Semin Dial 2007;20: 103-109.
6. Speer MY, Yang H-Y, Brabb T, Leaf E, Look A, Lin W-L et al. Smooth muscle cells give rise to osteochondrogenic precursors and chondrocytes in calcifying arteries. Circ Res 2009;104:733-741.
7. Wu SY, Zhang BH, Pan CS, Jiang HF, Pang YZ, Tang CS et al. Endothelin-1 is a potent regulator in vivo in vascular calcification and in vitro in calcification of vascular smooth muscle cells. Peptides 2003;24:1149-1156. (Pubitemid 37386301)
8. Huang Z, Li J, Jiang Z, Qi Y, Tang C, Du J. Effects of adrenomedullin, C-type natriuretic peptide, and parathyroid hormone-related peptide on calcification in cultured rat vascular smooth muscle cells. J Cardiovasc Pharmacol 2003;42:89-97. (Pubitemid 36791355)
9. Tintut Y, Demer LL. Recent advances in multifactorial regulation of vascular calcification. Curr Opin Lipidol 2001;12:555-560. (Pubitemid 32980305)
10. Bataller R, Schwabe RF, Choi YH, Yang L, Paik YH, Lindquist J et al. NADPH oxidase signal transduces angiotensin II in hepatic stellate cells and is critical in hepatic fibrosis. J Clin Invest 2003;112:1383-1394. (Pubitemid 38057692)
11. Byon CH, Javed A, Dai Q, Kappes JC, Clemens TL, Darley-Usmar VM et al. Oxidative stress induces vascular calcification through modulation of the osteogenic transcription factor Runx2 by AKT signaling. J Biol Chem 2008;283:15319-15327.
12. Schiffrin EL, Park JB, Intengan HD, Touyz RM. Correction of arterial structure and endothelial dysfunction in human essential hypertension by the angiotensin receptor antagonist losartan. Circulation 2000;101:1653-1659. (Pubitemid 30196624)
13. Yusuf S, Sleight P, Pogue J, Bosch J, Davies R, Dagenais G. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in highrisk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med 2000;342:145-153. (Pubitemid 30051645)
14. Henriksen EJ, Jacob S, Kinnick TR, Teachey MK, Krekler M. Selective angiotensin II receptor receptor antagonism reduces insulin resistance in obese Zucker rats. Hypertension 2001;38:884-890. (Pubitemid 34258687)
15. Igarashi M, Hirata A, Yamaguchi H, Tsuchiya H, Ohnuma H, Tominaga M et al. Candesartan inhibits carotid intimal thickening and ameliorates insulin resistance in balloon-injured diabetic rats. Hypertension 2001;38:1255-1259. (Pubitemid 34033398)
16. Jacobsen P, Andersen S, Rossing K, Jensen BR, Parving H-H. Dual blockade of the renin-angiotensin system versus maximal recommended dose of ACE inhibition in diabetic nephropathy. Kidney Int 2003;63:1874-1880. (Pubitemid 36513336)
17. Hoogwerf BJ. Renin-angiotensin system blockade and cardiovascular and renal protection. Am J Cardiol 2010;105:30A-35A.
18. Shobeiri N, Adams MA, Holden RM. Vascular calcification in animal models of CKD: a review. Am J Nephrol 2010;31:471-481.
19. Mizobuchi M, Towler DA, Slatopolsky E. Vascular calcification: the killer of patients with chronic kidney disease. J Am Soc Nephrol 2009;20:1453-1464.
20. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C et al. Endocrine regulation of energy metabolism by the skeleton. Cell 2007;130:456-469. (Pubitemid 47208519)
21. Ngo DTM, Stafford I, Kelly DJ, Sverdlov AL, Wuttke RD, Weedon H et al. Vitamin D(2) supplementation induces the development of aortic stenosis in rabbits: interactions with endothelial function and thioredoxin-interacting protein. Eur J Pharmacol 2008;590:290-296.
22. Drolet M-C, Arsenault M, Couet J. Experimental aortic valve stenosis in rabbits. J Am Coll Cardiol 2003;41:1211-1217. (Pubitemid 36384911)
23. Fishbein GA, Fishbein MC. Arteriosclerosis: rethinking the current classification. Arch Pathol Lab Med 2009;133:1309-1316.
24. Micheletti RG, Fishbein GA, Currier JS, Fishbein MC. Mönckeberg sclerosis revisited: a clarification of the histologic definition of Mönckeberg sclerosis. Arch Pathol Lab Med 2008;132:43-47.
25. Foley RN, Parfrey PS, Sarnak MJ. Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998;9:S16-S23.
26. Lehto S, Niskanen L, Suhonen M, Rönnemaa T, Laakso M. Medial artery calcification. A neglected harbinger of cardiovascular complications in non-insulin-dependent diabetes mellitus. Arterioscler Thromb Vasc Biol 1996;16:978-983. (Pubitemid 26266896)
27. Nelson RG, Gohdes DM, Everhart JE, Hartner JA, Zwemer FL, Pettitt DJ et al. Lowerextremity amputations in NIDDM. 12-yr follow-up study in Pima Indians. Diabetes Care 1988;11:8-16.
28. Liu Y, Zhou YB, Zhang GG, Cai Y, Duan XH, Teng X et al. Cortistatin attenuates vascular calcification in rats. Regul Pept 2010;159:35-43.
29. El-Abbadi MM, Pai AS, Leaf EM, Yang H-Y, Bartley BA, Quan KK et al. Phosphate feeding induces arterial medial calcification in uremic mice: role of serum phosphorus, fibroblast growth factor-23, and osteopontin. Kidney Int 2009;75:1297-1307.
30. Panizo S, Cardus A, Encinas M, Parisi E, Valcheva P, López-Ongil S et al. RANKL Increases vascular smooth muscle cell calcification through a RANK-BMP4-dependent pathway. Circ Res 2009;104:1041-1048.
31. Aikawa E, Aikawa M, Libby P, Figueiredo J-L, Rusanescu G, Iwamoto Y et al. Arterial and aortic valve calcification abolished by elastolytic cathepsin S deficiency in chronic renal disease. Circulation 2009;119:1785-1794.
32. Yang X, Fullerton DA, Su X, Ao L, Cleveland JC, Meng X. Pro-osteogenic phenotype of human aortic valve interstitial cells is associated with higher levels of Toll-like receptors 2 and 4 and enhanced expression of bone morphogenetic protein 2. J Am Coll Cardiol 2009;53:491-500.
33. Bas A, Lopez I, Perez J, Rodriguez M, Aguilera-Tejero E. Reversibility of calcitriol-induced medial artery calcification in rats with intact renal function. J Bone Miner Res 2006;21:484-490.
34. Zeadin M, Butcher M, Werstuck G, Khan M, Yee CK, Shaughnessy SG. Effect of leptin on vascular calcification in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 2009;29:2069-2075.
35. Nakano-Kurimoto R, Ikeda K, Uraoka M, Nakagawa Y, Yutaka K, Koide M et al. Replicative senescence of vascular smooth muscle cells enhances the calcification through initiating the osteoblastic transition. Am J Physiol Heart Circ Physiol 2009;297: H1673-H1684.
36. You H, Yang H, Zhu Q, Li M, Xue J, Gu Y et al. Advanced oxidation protein products induce vascular calcification by promoting osteoblastic trans-differentiation of smooth muscle cells via oxidative stress and ERK pathway. Ren Fail 2009;31:313-319.
37. Tanikawa T, Okada Y, Tanikawa R, Tanaka Y. Advanced glycation end products induce calcification of vascular smooth muscle cells through RAGE/p38 MAPK. J Vasc Res 2009;46:572-580.
38. Li X, Yang H-Y, Giachelli CM. BMP-2 promotes phosphate uptake, phenotypic modulation, and calcification of human vascular smooth muscle cells. Atherosclerosis 2008; 199:271-277.
39. Steitz SA, Speer MY, Curinga G, Yang HY, Haynes P, Aebersold R et al. Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers. Circ Res 2001;89: 1147-1154. (Pubitemid 34627872)
40. Bandow K, Nishikawa Y, Ohnishi T, Kakimoto K, Soejima K, Iwabuchi S et al. Lowintensity pulsed ultrasound (LIPUS) induces RANKL, MCP-1, and MIP-1beta expression in osteoblasts through the angiotensin II type 1 receptor. J Cell Physiol 2007;211:392-398. (Pubitemid 46580093)
41. Arishiro K, Hoshiga M, Negoro N, Jin D, Takai S, Miyazaki M et al. Angiotensin receptor-1 blocker inhibits atherosclerotic changes and endothelial disruption of the aortic valve in hypercholesterolemic rabbits. J Am Coll Cardiol 2007;49: 1482-1489. (Pubitemid 46482919)
42. Fliser D, Buchholz K, Haller H, EUropean Trial on Olmesartan and Pravastatin in Inflammation and Atherosclerosis (EUTOPIA) Investigators. Antiinflammatory effects of angiotensin II subtype 1 receptor blockade in hypertensive patients with microinflammation. Circulation 2004;110:1103-1107. (Pubitemid 39319009)